Top Takeaways from ACC.26
From Eagle's Eye View: Your Weekly CV Update From ACC.org · · 11 min
This plays from the publisher's own server. We do not host a copy.
Description
In this week's View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30. Important studies discussed include:
- CHAMPION-AF: Left atrial appendage closure vs. anticoagulation for AFib
- VESALIUS-CV: Evolocumab reduces CV risk in diabetic patients without ASCVD
- Ez-PAVE: Hitting lower LDL-C target reduces major CV events
- PRO-TAVI: Should high-risk patients undergo PCI before TAVI?
- SMART-DECISION: Discontinuing beta-blockers safe 1 year post MI For stable patients
- GoFreshRx: How home-delivered DASH groceries improve blood pressure (BP) and LDL-C
- THRIVE: Exploring the positive effects of a culturally tailored "food-is medicine" program on lowering BP
Back to Eagle's Eye View: Your Weekly CV Update From ACC.org · Report a problem